ArticleScientific reports2024

Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma.

Joo Whan Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.